Xagenic assets acquired by General Atomics
NewsJanuary 29, 2018
SAN DIEGO. Officials at General Atomics Electromagnetic Systems Group (GA-EMS) announced the acquisition of certain assets of Xagenic, Inc., a Toronto, Canada-based developer of molecular diagnostic systems.
The assets will be integrated into the new GA-EMS bio-sensor technology development operation located in Rancho Bernardo, California, to support the organization’s growth initiatives related to microelectronics, advanced sensors, and signal processing technologies for defense applications.
Xagenic developed a diagnostic system, which uses a unique, customizable cartridge containing a proprietary sensor chip to enable rapid, lab-quality molecular diagnostics for disease detection at the point of service. The diagnostic technology is completely automated within a single-use disposable cartridge and involves nanostructured microelectrode sensors allowing direct electrochemical analysis of the prepared sample on the cartridge. By fully automating steps that are typically performed by a laboratory technician, the system enables testing in settings where molecular methods might not be possible.
“The innovations Xagenic made in the design of ultrasensitive microelectronics and nano-sensors are highly complementary to our core strengths in developing and manufacturing complex, specialized electronic systems,” states Scott Forney, president of GA-EMS.
